Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03595449 · ClinicalTrials.gov registry record · Phase 4
Lidocaine Jelly for Pain Control During Mohs Surgery
A Phase 4 study of Pain and Satisfaction, Consumer, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 233
- Enrollment target
- 1
- Study location
NCT03595449: Completed Phase 4 study of Pain and Satisfaction, Consumer, sponsored by Mayo Clinic.
NCT03595449 is a Phase 4 study of Pain and Satisfaction, Consumer that has completed, run by Mayo Clinic. The registered enrollment target is 233 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03595449, a Phase 4 study of Pain and Satisfaction, Consumer, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 233 participants
- Enrollment target
- 1
- Study location
Study Summary
Does the use of lidocaine jelly during Mohs surgery on the nose decrease the total amount of lidocaine used during surgery. Does patient satisfaction improve when lidocaine jelly is used during Mohs surgery of the nose?
Primary Outcome
The mean change of total pain score of patient perception of pain. As measured by the question "Rate the pain of your nose from 0 to 10. 0 being no pain, 10 being the worst pain of your life."
Conditions Studied
Interventions
- DRUG Surgilube
- DRUG Lidocaine jelly
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2018-08-13 |
| Est. Completion | 2020-08-31 |
| Phase | Phase 4 |
What the finished NCT03595449 record still lists
NCT03595449 is an interventional study that assigns participants to a tested intervention. The registered 233 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (23% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Surgilube is the first listed.
NCT03595449 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT03595449 about?
NCT03595449 is a clinical study titled "Lidocaine Jelly for Pain Control During Mohs Surgery". Does the use of lidocaine jelly during Mohs surgery on the nose decrease the total amount of lidocaine used during surgery. Does patient satisfaction improve when lidocaine jelly is used during Mohs surgery of the nose?
What is the current status of trial NCT03595449?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 233 participants. The study started on 2018-08-13. Estimated completion is 2020-08-31.
What conditions does trial NCT03595449 study?
This clinical trial studies the following conditions: Pain, Satisfaction, Consumer.
What interventions are being tested in trial NCT03595449?
The interventions under investigation include: Surgilube (DRUG), Lidocaine jelly (DRUG).
Who is sponsoring clinical trial NCT03595449?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03595449 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03595449's enrollment target sits among peer trials
233 77th of 374 higher than 298 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Magnesium on Neuromonitoring
RECRUITING · Phase 4
-
Low-Dose Ketamine Infusion During Burn Wound Care
RECRUITING · Phase 4
-
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
RECRUITING · Phase 4
-
Optimizing Pain Control in Transurethral Resection of the Prostate
RECRUITING · Phase 4
-
Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia
RECRUITING · Phase 4
-
Regional Blocks for Lateral Condyle Fractures
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06993844 · 233 participants · Phase 1
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- NCT07141706 · 233 participants · Phase 1
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI